Callejas Blanca E, Sousa James A, Flannigan Kyle L, Wang Arthur, Higgins Eve, Herik Aydin I, Li Shuhua, Rajeev Sruthi, Rosentreter Ryan, Panaccione Remo, McKay Derek M
Gastrointestinal Research Group, Inflammation Research Network and Host-Parasite Interactions Group, Department of Physiology and Pharmacology, Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Division of Gastroenterology and Hepatology, Gastrointestinal Research Group, Department of Medicine, Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Am J Physiol Gastrointest Liver Physiol. 2025 Jan 1;328(1):G1-G16. doi: 10.1152/ajpgi.00159.2024. Epub 2024 Oct 8.
Interleukin-4 activated human macrophages [M(IL4)s] promote epithelial wound healing and exert an anticolitic effect in a murine model. Blood monocyte-derived M(IL4)s from healthy donors and individuals with Crohn's disease had increased mRNA expression of the calcitonin gene-related peptide (CGRP) receptor chain, receptor activity modifying protein-1 (RAMP1), raising the issue of neural modulation of the M(IL4)s reparative function. Thus, human M(IL4)s were treated with CGRP and the cells' phagocytotic, epithelial wound repair and anticolitic functions were assessed. Initial studies confirmed upregulation of expression of the CGRP receptor, which was localized to the cell surface and was functional as determined by CGRP-evoked increases in cAMP. M(IL4,CGRP)s had increased mannose receptor (CD206) and FcγRIIa (CD32a) mRNA expression, a subtle, but significant, increase in phagocytosis and decreased chemokine production following the exposure to . When delivered systemically (10 cells IP) to oxazolone-treated mice, M(IL4,CGRP) had an anticolitic effect superior to M(IL4)s from the same blood donor. Conditioned medium (CM) from M(IL4,CGRP) had increased amounts of transforming growth factor (TGF)-β and increased wound-healing capacity compared with matched M(IL4)-CM in the human CaCo epithelial cell line in-vitro wounding assay. Moreover, M(IL4,CGRP)s displayed increased cyclooxygenase (COX)-1 and prostaglandin D (PGD), and CM from M(IL4,CGRP)s treated with indomethacin or SC-560 to inhibit COX-1 activity failed to promote repair of wounded CaCo cell monolayers. These data confirm the human M(IL4)s' anticolitic effect that was enhanced by CGRP and may be partially dependent on macrophage COX-1/PGD activity. Thus, input from neurone-derived molecules is a local modifier capable of boosting the anticolitic effect of autologous M(IL4) transfer. A novel pathway is identified whereby interleukin-4-educated human macrophages [M(IL4)s] exposed to calcitonin gene-related peptide (CGRP) reduce oxazolone-induced colitis and promote epithelial wound healing in vitro through COX1-dependent signaling. Support is provided for the concept of macrophage transfer to treat enteric inflammation where neuroimmune interaction, in this case CGRP neuropeptide, produced under inflammatory conditions will reinforce the anticolitic and wound repair capacity of M(IL4) autologous-based therapy for IBD treatment.
白细胞介素-4激活的人巨噬细胞[M(IL4)s]可促进上皮伤口愈合,并在小鼠模型中发挥抗结肠炎作用。来自健康供体和克罗恩病患者的血液单核细胞衍生的M(IL4)s,其降钙素基因相关肽(CGRP)受体链、受体活性修饰蛋白-1(RAMP1)的mRNA表达增加,这引发了对M(IL4)s修复功能神经调节的问题。因此,用CGRP处理人M(IL4)s,并评估细胞的吞噬、上皮伤口修复和抗结肠炎功能。初步研究证实CGRP受体表达上调,该受体定位于细胞表面且具有功能,这可通过CGRP引起的cAMP增加来确定。M(IL4,CGRP)s的甘露糖受体(CD206)和FcγRIIa(CD32a)mRNA表达增加,吞噬作用有细微但显著的增加,且在暴露于……后趋化因子产生减少。当将M(IL4,CGRP)全身给药(10个细胞腹腔注射)给恶唑酮处理的小鼠时,其抗结肠炎作用优于来自同一献血者的M(IL4)s。在体外伤口愈合试验中,与匹配的M(IL4)条件培养基(CM)相比,M(IL4,CGRP)的条件培养基中转化生长因子(TGF)-β含量增加且伤口愈合能力增强。此外,M(IL4,CGRP)s的环氧化酶(COX)-1和前列腺素D(PGD)增加,用吲哚美辛或SC-560处理以抑制COX-1活性的M(IL4,CGRP)s的CM未能促进受伤的CaCo细胞单层的修复。这些数据证实了CGRP增强了人M(IL4)s的抗结肠炎作用,且可能部分依赖于巨噬细胞COX-1/PGD活性。因此,神经元衍生分子的输入是一种局部调节剂,能够增强自体M(IL4)转移的抗结肠炎作用。确定了一条新途径,即暴露于降钙素基因相关肽(CGRP)的白细胞介素-4诱导的人巨噬细胞[M(IL4)s]通过COX1依赖性信号传导减少恶唑酮诱导的结肠炎并促进体外上皮伤口愈合。为巨噬细胞转移治疗肠道炎症的概念提供了支持,在这种情况下,炎症条件下产生的神经免疫相互作用,即CGRP神经肽,将增强基于M(IL4)自体疗法治疗炎症性肠病的抗结肠炎和伤口修复能力。